Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to September 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.4B |
| Sales growthchange from the year before | -4.9% |
| Gross marginshare of sales left after the direct cost of what it sells | 43.7% |
| Operating marginshare of sales left after running the business | -3.5% |
| Net marginshare of sales kept as profit | -4.2% |
| Return on invested capitalprofit made on each $100 put into the business | -9.0% |
| Return on equityprofit vs. shareholders' accounting value | -13.8% |
| Change in share countnegative = the company is buying back its shares | -2.0% |
1 insider sold $665K (all under pre-arranged plans) on the open market.
| Genachowski JuliusDirector | Sold (plan)Jul 29 | 19,855 shat $17.00 · $338K |
| Genachowski JuliusDirector | Sold (plan)Jul 28 | 19,855 shat $16.50 · $328K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy